Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunt...

by Wannee Kantakamalakul, Mark De Souza, Chitraporn Karnasuta, Arthur Brown, Sanjay Gurunathan, Deborah Birx, Prasert Thongcharoen, The Taveg
Published 2018

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand

by Chitraporn Karnasuta, Robert M. Paris, Josephine H. Cox, Sorachai Nitayaphan, Punnee Pitisuttithum, Prasert Thongcharoen, Arthur E. Brown, Sanjay Gurunathan, James Tartaglia, William L. Heyward, John G. McNeil, Deborah L. Birx, Mark S. De Souza
Published 2018

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX ® B...

by Robert Paris, Sasitorn Bejrachandra, Prasert Thongcharoen, Sorachai Nitayaphan, Punnee Pitisuttithum, Anna Sambor, Sanjay Gurunathan, Donald Francis, Silvia Ratto-Kim, Chitraporn Karnasuta, Mark S. de Souza, Victoria R. Polonis, Arthur E. Brown, Jerome H. Kim, Henry A. Stephens
Published 2018

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID...

by Prasert Thongcharoen, Vinai Suriyanon, Robert M. Paris, Chirasak Khamboonruang, Mark S. De Souza, Silvia Ratto-Kim, Chitraporn Karnasuta, Victoria R. Polonis, Lynn Baglyos, Raphaelle El Habib, Sanjay Gurunathan, Susan Barnett, Arthur E. Brown, Deborah L. Birx, John G. McNeil, Jerome H. Kim
Published 2018

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID...

by Prasert Thongcharoen, Vinai Suriyanon, Robert M. Paris, Chirasak Khamboonruang, Mark S. De Souza, Silvia Ratto-Kim, Chitraporn Karnasuta, Victoria R. Polonis, Lynn Baglyos, Raphaelle El Habib, Sanjay Gurunathan, Susan Barnett, Arthur E. Brown, Deborah L. Birx, John G. McNeil, Jerome H. Kim
Published 2018

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A post-hoc analysis of the Thai phase 3 efficacy trial RV 144

by Merlin L. Robb, Supachai Rerks-Ngarm, Sorachai Nitayaphan, Punnee Pitisuttithum, Jaranit Kaewkungwal, Prayura Kunasol, Chirasak Khamboonruang, Prasert Thongcharoen, Patricia Morgan, Michael Benenson, Robert M. Paris, Joseph Chiu, Elizabeth Adams, Donald Francis, Sanjay Gurunathan, Jim Tartaglia, Peter Gilbert, Don Stablein, Nelson L. Michael, Jerome H. Kim
Published 2018

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand

by Rasmi Thomas, Danaya Chansinghakul, Kriengsak Limkittikul, Peter B. Gilbert, Weerawan Hattasingh, Zoe Moodie, Shida Shangguan, Carina Frago, Wut Dulyachai, Shuying Sue Li, Richard G. Jarman, Aviva Geretz, Alain Bouckenooghe, Arunee Sabchareon, Michal Juraska, Philip Ehrenberg, Nelson L. Michael, Fabrice Bailleux, Chris Bryant, Sanjay Gurunathan
Published 2022

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults

by Sorachai Nitayaphan, Punnee Pitisuttithum, Chitraporn Karnasuta, Chirapa Eamsila, Mark De Souza, Patricia Morgan, Victoria Polonis, Michael Benenson, Tom VanCott, Silvia Ratto-Kim, Jerome Kim, Darawan Thapinta, Robin Garner, Valai Bussaratid, Pricha Singharaj, Raphaelle El Habib, Sanjay Gurunathan, William Heyward, Deborah Birx, John McNeil, Arthur E. Brown
Published 2018

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

by Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, Jittima Dhitavat, Wirach Maekanantawat, Swangjai Pungpak, Pravan Suntharasamai, Sirivan Vanijanonta, Sorachai Nitayapan, Jaranit Kaewkungwal, Michael Benenson, Patricia Morgan, Robert J. O'Connell, Jeffrey Berenberg, Sanjay Gurunathan, Donald P. Francis, Robert Paris, Joseph Chiu, Donald Stablein, Nelson L. Michael, Jean Louis Excler, Merlin L. Robb, Jerome H. Kim
Published 2018

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

by Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Jaranit Kaewkungwal, Joseph Chiu, Robert Paris, Nakorn Premsri, Chawetsan Namwat, Mark De Souza, Elizabeth Adams, Michael Benenson, Sanjay Gurunathan, Jim Tartaglia, John G. McNeil, Donald P. Francis, Donald Stablein, Deborah L. Birx, Supamit Chunsuttiwat, Chirasak Khamboonruang, Prasert Thongcharoen, Merlin L. Robb, Nelson L. Michael, Prayura Kunasol, Jerome H. Kim
Published 2018

Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E

by Supachai Rerks-Ngarm, Robert M. Paris, Supamit Chunsutthiwat, Nakorn Premsri, Chawetsan Namwat, Chureeratana Bowonwatanuwong, Shuying S. Li, Jaranit Kaewkungkal, Rapee Trichavaroj, Nampueng Churikanont, Mark S. De Souza, Charla Andrews, Donald Francis, Elizabeth Adams, Jorge Flores, Sanjay Gurunathan, Jim Tartaglia, Robert J. O'Connell, Chirapa Eamsila, Sorachai Nitayaphan, Viseth Ngauy, Prasert Thongcharoen, Prayura Kunasol, Nelson L. Michael, Merlin L. Robb, Peter B. Gilbert, Jerome H. Kim
Published 2018

The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120

by Nicos Karasavvas, Erik Billings, Mangala Rao, Constance Williams, Susan Zolla-Pazner, Robert T. Bailer, Richard A. Koup, Sirinan Madnote, Duangnapa Arworn, Xiaoying Shen, Georgia D. Tomaras, Jeffrey R. Currier, Mike Jiang, Craig Magaret, Charla Andrews, Raphael Gottardo, Peter Gilbert, Timothy J. Cardozo, Supachai Rerks-Ngarm, Sorachai Nitayaphan, Punnee Pitisuttithum, Jaranit Kaewkungwal, Robert Paris, Kelli Greene, Hongmei Gao, Sanjay Gurunathan, Jim Tartaglia, Faruk Sinangil, Bette T. Korber, David C. Montefiori, John R. Mascola, Merlin L. Robb, Barton F. Haynes, Viseth Ngauy, Nelson L. Michael, Jerome H. Kim, Mark S. De Souza
Published 2018

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

by Mark S. De Souza, Silvia Ratto-Kim, Weerawan Chuenarom, Alexandra Schuetz, Somsak Chantakulkij, Bessara Nuntapinit, Anais Valencia-Micolta, Doris Thelian, Sorachai Nitayaphan, Punnee Pitisuttithum, Robert M. Paris, Jaranit Kaewkungwal, Nelson L. Michael, Supachai Rerks-Ngarm, Bonnie Mathieson, Mary Marovich, Jeffrey R. Currier, Jerome H. Kim, Supamit Chunsuttiwat, Nakorn Premsri, Chawetsan Namwat, Prayura Kunasol, Prasert Thongcharoen, Chirasak Khamboonruang, Valai Bussaratid, Wirach Maek-a-nantawat, Jittima Dhitavat, Pravan Suntharasamai, Swangjai Pungpak, Siriwan Vanijanonta, Jaranit Kaewkunwal, Amnat Khamsiriwatchara, Pawinee Jarujareet, Chirapa Easmila, Suchana Tabprasit, Viseth Ngauy, Robert Paris, Michael Benenson, Patricia Morgan, Arthur Brown, Mark De Souza, Rapee Trichavaroj, Nusara Thaitawat, Kanyasiri Kongnonkok, Boot Keawboon, Yuwadee Phuang-Ngern, Susan Mason, Sanjay Gurunathan, Jim Tartaglia, John G. McNeil, Robin Harkness, Claude Meric, Lynn Baglyos, Raphaelle El Habib, Don Francis, Carter Lee, Elizabeth Adams, Merlin L. Robb, Mark Milazzo, Amy Bolen, Beryl Wessner, Jeffrey Currier, Deborah L. Birx, Don Stablein, Terry Germanson, Len Dally, Jean Louis Excler, Jeffrey Berenberg
Published 2018